Flagship and GSK announce a strategic collaboration to discover and develop a portfolio of novel medicines and vaccines, starting in respiratory and immunology. Read the full announcement about our latest Innovation Supply Chain Partnership which will leverage GSK’s disease expertise and development capability together with Flagship’s ecosystem of pioneering bioplatforms: https://bit.ly/4d0aed8
Flagship Pioneering
Biotechnology Research
Cambridge, MA 99,176 followers
We are a biotechnology company that invents and builds platform companies that change the world.
About us
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises over 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, and Tessera Therapeutics.
- Website
-
http://www.flagshippioneering.com
External link for Flagship Pioneering
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Cambridge, MA
- Type
- Privately Held
- Founded
- 2000
- Specialties
- life sciences, biotech, therapeutics, diagnostics, sustainability, climate change, artificial intelligence, machine learning, agtech, medicines, therapeutics, biology, entrepreneurship, biotechnology, science, innovation, and ventures
Locations
-
Primary
55 Cambridge Parkway
Suite 800E
Cambridge, MA 02142, US
Employees at Flagship Pioneering
-
Karim Lakhani
Professor Harvard Business School | Chair D^3 Institute at Harvard | Board Member, Mozilla Corporation & VideaHealth | Academic Partner, Flagship…
-
Venu Nagali
Strategy, Business Development & Finance Executive ✦ Increase Enterprise Value through Innovative Strategies and Building Results-Producing Teams
-
Susan Vidal
Strategic HR Leader & Employee Retention Evangelist
-
David Khougazian
Growth Partner at Flagship Pioneering
Updates
-
Flagship Pioneering reposted this
We’re thrilled to announce our Chief Innovation Officer, Vinidhra Mani has been named a 2024 Boston Business Journal 40 under 40 honoree! As a founding team member, Vini’s leadership and contributions have been invaluable to our rapid growth and success illuminating the #ExpandedProteome. We're honored to have her as a member of the ProFound team and look forward to the continued impact she'll have in the world of #biotech and the Greater Boston community. Congratulations to all the honorees. Check out the full list here: https://bit.ly/3MpEm5X #BBJ4040
-
-
Congratulations to Armen Mkrtchyan, Flagship Origination Partner & Head of Pioneering Intelligence, and Vinidhra Mani, Flagship Principal & Chief Innovation Officer of #FlagshipFounded ProFound Therapeutics, on being named on Boston Business Journal's 40 Under 40 list of professionals making a difference in their organizations and communities: https://lnkd.in/e_4s-Dtm #BBJ4040
-
-
Flagship Pioneering reposted this
Today we announced two research programs through Flagship Pioneering's strategic partnership with Pfizer to identify potential novel targets for the treatment of #cardiovascular and #renal diseases. Under the agreement, our #SomaticGenomics platform will analyze somatic mutations in diseased patient tissue to inform the discovery and development of potentially transformative therapies. Learn more: https://bit.ly/473ta8w
-
-
The Innovation Supply Chain partnership we are advancing with Pfizer represents a new model of R&D for the industry. Hear more about how we are working together to rapidly advance a pipeline of transformational medicines including with our latest collaboration with Quotient Therapeutics: https://bit.ly/3yZlIi9. #BiggerLeaps
-
Flagship and #FlagshipFounded Quotient Therapeutics announce a collaboration to identify potential novel targets for the treatment of cardiovascular and renal diseases under Flagship’s strategic partnership with Pfizer. Read the full announcement: https://bit.ly/3yZlIi9
-
-
Hear from Marcello Damiani, Flagship Senior Partner, on his career in the digital field, how AI is going to change drug development, and what keeps him busy outside of the office.
-
Click through our newest Life Illustrated profile to learn about Armen Mkrtchyan, Flagship Origination Partner & Head of Pioneering Intelligence, and his journey from growing up in a small town in Armenia and studying in North Dakota and at MIT to developing expertise in AI technology and leading Flagship’s Pioneering Intelligence Initiative: https://bit.ly/3T6cTdf
-
#FlagshipFounded Ring Therapeutics explains the structure of an anellovirus and its mechanism for immune evasion in a recent publication in Nature Portfolio as the company continues to advance its pioneering Anellogy™ platform to make bigger leaps in genetic medicine. For more on Ring, tune in to hear CEO of Ring Tuyen Ong and Ring cofounder Avak Kahvejian on how the company made such rapid progress in turning an obscure virus into a new vehicle for genetic medicines: https://bit.ly/3wLnySz
We're thrilled to share our recent publication in Nature Portfolio showcasing the unique structure of anelloviruses. By leveraging their structurally-derived immune evasion properties, our team is developing potentially safer vectors through our novel Anellogy™ platform to transform the future of #GeneticMedicines. To learn more about anelloviruses and the promise they hold in the #GeneticMedicine space, read here: https://lnkd.in/gCdPNqeD
-
Flagship Pioneering reposted this
We announced today that the European Commission has granted marketing authorization for our mRNA respiratory syncytial virus (RSV) vaccine. The marketing authorization follows the Positive Opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). Read more: https://lnkd.in/e6rDu_zs
-